Plant Comparison
Saffron vs Flaxseed
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Saffron and Flaxseed: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Saffron | Flaxseed | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 3/10 | Stronger for Flaxseed |
| Cancer (anticancer research) | 8/10 | 7/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 3/10 | Stronger for Flaxseed |
| Metabolic support | 1/10 | 6/10 | Stronger for Flaxseed |
| Skin irritation | 1/10 | 3/10 | Stronger for Flaxseed |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.
The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.
The main bitter-tasting glycoside of the stigma, a precursor of safranal.
Flax is the richest dietary source of SDG-type lignans, converted by gut bacteria to the mammalian lignans enterodiol and enterolactone; studied for antioxidant and hormone-modulating activity.
The dominant fatty acid of the seed oil (~50-55% of total oil), a plant-based omega-3 studied for cardiovascular and anti-inflammatory effects.
Concentrated in the seed coat; gives flaxseed its demulcent, laxative, bulk-forming action.
Present at low levels; cooking/roasting reduces them to negligible amounts in normal food use - a theoretical concern only at high raw intakes.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.
Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).
Flaxseeds are safe for most people at recommended food amounts (1–2 tablespoons ground/day). They must be ground or milled to be bioavailable — whole seeds largely pass through the gut undigested. High fibre content may cause bloating, flatulence, and loose stools, especially if fibre intake is increased rapidly without adequate hydration. Flaxseeds contain cyanogenic glycosides (linamarin, linustatin); cooking or roasting reduces these to negligible levels in normal food amounts. Raw seeds in very large quantities are a theoretical concern, but typical use is safe (EFSA, 2017).
Medication interactions: Flaxseed may reduce absorption of oral medications if taken simultaneously — space flaxseed supplementation 1–2 hours from medications. Omega-3 ALA and lignans may mildly enhance anticoagulant/antiplatelet effects; use caution with blood thinners. Some sources suggest caution with hormone-sensitive conditions due to phytoestrogen (lignan) content, though dietary amounts are unlikely to pose risk (Adolphe et al., 2010).
Pregnancy: Food amounts are generally considered safe; high-dose supplements should be discussed with a clinician due to limited safety data.
Duke (2002) rates flaxseed as +++ with clinical evidence (score 2) for antiatherogenic, hypocholesterolemic, laxative, lipolytic (fat-dissolving), and demulcent activities. Flaxseed's omega-3 fatty acids (ALA) and lignans are associated with reduced cardiovascular risk. Commission E approves flaxseed as a laxative and for mucilaginous protection of inflamed gastrointestinal mucosa. Dose: 1–2 tablespoons ground seed with ample water, twice daily. Whole seeds should be chewed or ground for full medicinal effect. Cyanogenic glycosides are present but at safe levels in normal dietary amounts (Duke, 2002).
External Ids
Botanical Description
Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.
Erect annual herb, slender and often branched near the top, growing 30-80 (up to 100) cm tall from a fine taproot. Leaves are alternate, sessile, narrowly lanceolate to linear, blue-green and entire-margined. Flowers are pale blue (occasionally white or pink), five-petalled and borne on slender stalks in loose terminal cymes. The fruit is a small globular capsule ('boll') that splits into ten compartments, each containing one flattened, glossy, red-brown seed.[5]
Habitat
Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.
Native to the Mediterranean region and the Fertile Crescent, cultivated since prehistory for fibre and oil and now grown worldwide in temperate regions with well-drained, fertile soils and a cool, moist growing season; occasionally found as a naturalised escape on waste and cultivated ground.[5]
Harvesting
The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.
Grown as an annual crop, seed is harvested once the capsules ('bolls') have dried and turned brown, typically in late summer, by cutting or combining the whole plant and threshing out the seed. Whole seed stores well; it should only be ground shortly before use, since the oil in ground seed oxidises and turns rancid quickly.[2]
Traditional Uses
Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]
Flaxseed has a long history of traditional use as a bulk-forming laxative and demulcent for constipation and irritated gut mucosa, and as a poultice for boils and inflamed skin. Modern interest centres on its lignan (secoisolariciresinol diglucoside) and alpha-linolenic acid content, studied for cardiovascular, metabolic and hormone-related outcomes.[2, 4, 5]
Preparations
Stigma extract standardised to safranal/crocin content, taken as capsules; the form used in most clinical mood and metabolic studies.
Whole seed freshly ground (milled) and taken with plenty of liquid, or stirred into food; grinding is needed to make the oil and lignans bioavailable, as whole seeds largely pass through the gut undigested.
Cold-pressed oil taken as a concentrated source of alpha-linolenic acid (omega-3); lacks the fibre and lignan content of the whole ground seed.
Dosage
Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.
Traditional guidance and Duke (2002) suggest 1-2 tablespoons of ground seed with ample water, once or twice daily. Educational reference only, not a prescription.
A randomised placebo-controlled trial titrated flax oil capsules (550 mg alpha-linolenic acid per 1 g of oil) to 12 capsules per day, i.e. up to roughly 12 g of oil daily, over 16 weeks - broadly matching the 1-2 tablespoons (about 10-15 mL) daily often cited for omega-3 intake. That trial was in children and adolescents with bipolar disorder and its primary outcomes were null; it is cited here only as a source for an administered human dose of the oil, not as evidence of benefit. Note the EU herbal monograph on Lini semen covers the SEED, not the oil. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
https://doi.org/10.1093/nutrit/nuae076 - Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
https://doi.org/10.1002/hup.2434 - Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
https://doi.org/10.1016/j.jep.2022.115719 - Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
https://doi.org/10.3736/jintegrmed2013056 - Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
https://doi.org/10.1016/j.ctim.2017.06.001 - Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
https://doi.org/10.1089/cap.2018.0146 - Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
https://doi.org/10.1055/s-0034-1375681 - Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.6b04398 - Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
https://doi.org/10.1002/ptr.5622 - Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2014.10.009 - Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2018.03.041 - El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
https://doi.org/10.3390/nu14030597 - Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
https://doi.org/10.3390/molecules26051237 - Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L - Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
https://scholar.google.com/scholar?q=Avicenna - Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
https://scholar.google.com/scholar?q=Crocus%20sativus%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
https://doi.org/10.1016/j.jad.2014.11.035 - Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
https://doi.org/10.1055/a-0660-9565 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
https://doi.org/10.3389/fnut.2024.1349006 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ - Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
https://bygl.osu.edu/node/1458
- Picur, B., Cebrat, M., Zabrocki, J. and Siemion, I.Z (2006) 'Cyclopeptides of Linum usitatissimum', Journal of Peptide Science, 12(9), pp. 569-574. doi:10.1002/psc.779 Preclinical
https://doi.org/10.1002/psc.779 - Basch, E., Bent, S., Collins, J., Dacey, C., Hammerness, P., Harrison, M., Smith, M., Szapary, P., Ulbricht, C., Vora, M. and Weissner, W (2007) 'Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration', Journal of the Society for Integrative Oncology, 5(3), pp. 92-105. doi:10.2310/7200.2007.005 Meta-analysis / review
https://doi.org/10.2310/7200.2007.005 - Chhillar, H., Chopra, P. and Ashfaq, M.A (2020) 'Lignans from linseed (Linum usitatissimum L.) and its allied species: retrospect, introspect and prospect', Critical Reviews in Food Science and Nutrition, 61(16), pp. 2719-2741. doi:10.1080/10408398.2020.1784840 Meta-analysis / review
https://doi.org/10.1080/10408398.2020.1784840 - Ansari, R., Zarshenas, M.M. and Dadbakhsh, A.H (2019) 'A review on pharmacological and clinical aspects of Linum usitatissimum L', Current Drug Discovery Technologies, 16(2), pp. 148-158. doi:10.2174/1570163815666180521101136 Meta-analysis / review
https://doi.org/10.2174/1570163815666180521101136 - Akter, Y., Junaid, M., Afrose, S.S., Nahrin, A., Alam, M.S., Sharmin, T., Akter, R. and Hosen, S.M.Z (2021) 'A comprehensive review on Linum usitatissimum medicinal plant: its phytochemistry, pharmacology, and ethnomedicinal uses', Mini Reviews in Medicinal Chemistry, 21(18), pp. 2801-2834. doi:10.2174/1389557521666210203153436 Meta-analysis / review
https://doi.org/10.2174/1389557521666210203153436 - Musazadeh, V., Abolghasemian, M., Kavyani, Z., Moridpour, A.H., Nazari, A. and Faghfouri, A.H (2024) 'The effects of flaxseed (Linum usitatissimum) supplementation on anthropometric indices: an updated systematic review and meta-analysis of randomized clinical trials', Complementary Therapies in Medicine, 84, pp. 103066. doi:10.1016/j.ctim.2024.103066 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2024.103066 - Mueed, A., Shibli, S., Jahangir, M., Jabbar, S. and Deng, Z (2022) 'A comprehensive review of flaxseed (Linum usitatissimum L.): health-affecting compounds, mechanism of toxicity, detoxification, anticancer and potential risk', Critical Reviews in Food Science and Nutrition, 63(32), pp. 11081-11104. doi:10.1080/10408398.2022.2092718 Meta-analysis / review
https://doi.org/10.1080/10408398.2022.2092718 - Kaithwas, G., Mukherjee, A., Chaurasia, A.K. and Majumdar, D.K (2011) 'Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil', Indian Journal of Experimental Biology, 49(12), pp. 932-938. Preclinical
https://scholar.google.com/scholar?q=Anti-inflammatory%2C%20analgesic%20and%20antipyretic%20activities%20of%20Linum%20usitatissimum%20L.%20%28flaxseed/linseed%29%20fixed%20oil - Rafieian-Kopaei, M., Shakiba, A., Sedighi, M. and Bahmani, M (2017) 'The analgesic and anti-inflammatory activity of Linum usitatissimum in Balb/c mice', Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), pp. 892-896. doi:10.1177/2156587217717416 Preclinical
https://doi.org/10.1177/2156587217717416 - Sirotkin, A.V (2023) 'Influence of flaxseed (Linum usitatissimum) on female reproduction', Planta Medica, 89(6), pp. 608-615. doi:10.1055/a-2013-2966 Meta-analysis / review
https://doi.org/10.1055/a-2013-2966 - Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K. and Goss, P.E (2006) 'Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer', 11(10), pp. 3828--3835. doi:10.1158/1078-0432.CCR-04-2326 Randomized trial
https://doi.org/10.1158/1078-0432.CCR-04-2326 - Adolphe, J.L., Whiting, S.J., Juurlink, B.H.J., Thorpe, L.U. and Alcorn, J (2010) 'Health effects with consumption of the flax lignan secoisolariciresinol diglucoside', 103(7), pp. 929--938. doi:10.1017/S0007114509992753 Clinical study
https://doi.org/10.1017/S0007114509992753 - Caligiuri, S.P.B., Edel, A.L., Aliani, M. and Pierce, G.N (2014) 'Flaxseed for hypertension: implications for improved cardiovascular risk', 16(12), pp. 499. doi:10.1007/s11906-014-0499-8 Randomized trial
https://doi.org/10.1007/s11906-014-0499-8 - European Food Safety Authority (2017) 'Safety of cyanogenic glycosides from flaxseed consumed as part of a usual diet', 15(11). doi:10.2903/j.efsa.2017.5026 Preclinical
https://doi.org/10.2903/j.efsa.2017.5026 - Harris, W.S (2012) 'Stearidonic acid as a surrogate for eicosapentaenoic acid in cardiovascular risk reduction: update and recommendation', 70(10), pp. 565--574. Traditional / reference
https://scholar.google.com/scholar?q=Stearidonic%20acid%20as%20a%20surrogate%20for%20eicosapentaenoic%20acid%20in%20cardiovascular%20risk%20reduction%3A%20update%20and%20recommendation - Latvijas valsts mežzinātnes institūts (n.d.) 'Linsēkla Latvijā'. Available at: https://www.silava.lv Traditional / reference
https://www.silava.lv - Pan, A., Sun, J., Chen, Y. et al (2009) 'Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial', 4(11). doi:10.1371/journal.pone.0007654 Randomized trial
https://doi.org/10.1371/journal.pone.0007654 - Royal Botanic Gardens, Kew (n.d.) 'Linum usitatissimum L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 - Gracious, B.L., Chirieac, M.C., Costescu, S., Finucane, T.L., Youngstrom, E.A. and Hibbeln, J.R (2010) 'Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder', Bipolar Disorders, 12(2), pp. 142-154. doi:10.1111/j.1399-5618.2010.00799.x Randomized trial
https://doi.org/10.1111/j.1399-5618.2010.00799.x - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.